GO:0004966 galanin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004966 (galanin receptor activity) is a molecular function defined as combining with galanin to initiate a change in cell activity.
• Three galanin receptor subtypes (GALR1, GALR2, GALR3) mediate galanin signaling through G protein-coupled receptor pathways.
• Galanin receptor activity is implicated in epilepsy, depression-like behavior, anxiety, and neuroprotection.
• Structural studies have revealed how galanin binds and activates its receptors, informing drug design.
• Nonpeptide agonists such as galnon show anticonvulsant and anxiolytic-like activity in preclinical models.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable causal dissection of galanin receptor function.
Description
Galanin receptor activity (GO:0004966) is a molecular function that mediates the cellular response to the neuropeptide galanin. This activity is essential for translating extracellular galanin signals into intracellular changes, influencing neuronal excitability, mood, and seizure susceptibility. Researchers study this term to understand how galanin and its receptors contribute to neurological and psychiatric disorders, and to develop targeted therapeutics. The three known galanin receptor subtypes, GALR1, GALR2, and GALR3, are G protein-coupled receptors that exhibit distinct expression patterns and signaling properties. Dysregulation of galanin receptor activity has been linked to epilepsy, depression, and anxiety, making it a compelling target for drug discovery. This article provides a research-grade overview of GO:0004966, covering its definition, mechanism, key genes, disease relevance, and experimental approaches.
galanin receptor activity At A Glance
| GO ID | GO:0004966 |
|---|---|
| GO term | galanin receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding galanin to initiate intracellular signaling |
| Receptor subtypes | GALR1, GALR2, GALR3 |
| Signaling mechanism | G protein-coupled receptor signaling |
| Associated diseases | Epilepsy, depression, anxiety |
What Is GO:0004966?
According to the Gene Ontology, galanin receptor activity (GO:0004966) is defined as combining with galanin to initiate a change in cell activity. This molecular function is executed by receptor proteins that bind galanin, a neuropeptide, and transduce its signal across the cell membrane, typically via G protein-coupled receptor mechanisms.
Why Is galanin receptor activity Important in Cell Biology?
Galanin receptor activity is critical for neuromodulation and has been implicated in a range of physiological and pathological processes. Understanding this function helps elucidate how galanin controls neuronal excitability, mood, and seizure thresholds, and supports the development of therapeutics for epilepsy, depression, and anxiety disorders.
• Regulates neuronal excitability and seizure susceptibility.
• Modulates depression-like and anxiety-like behaviors.
• Provides targets for anticonvulsant drug development.
• Involved in neuroprotective and analgesic mechanisms.
• Three receptor subtypes offer specificity for drug design.
• Nonpeptide agonists demonstrate therapeutic potential.
• Structural insights enable rational drug discovery.
• Links galanin signaling to mood disorders.
• Potential role in epilepsy pathophysiology.
• Model systems allow causal gene-function studies.
Molecular Mechanism of galanin receptor activity
Galanin Binding and Receptor Activation
In simple terms: Galanin binds to its receptor like a key in a lock, turning on the receptor.
Galanin, a 29-30 amino acid neuropeptide, binds to the extracellular domains of galanin receptors (GALR1, GALR2, GALR3), inducing conformational changes that activate the receptor. This binding is highly specific and initiates intracellular signaling cascades.
G Protein-Coupled Signaling
In simple terms: Activated receptors talk to G proteins inside the cell to pass on the signal.
Galanin receptors are G protein-coupled receptors (GPCRs). Upon galanin binding, they activate heterotrimeric G proteins, leading to downstream effects such as inhibition of adenylyl cyclase, modulation of ion channels, or activation of phospholipase C, depending on the receptor subtype.
Receptor Subtype Diversity
In simple terms: Different receptor subtypes can trigger different cellular responses.
GALR1, GALR2, and GALR3 couple to distinct G protein subtypes and exhibit different expression patterns, contributing to the diverse physiological effects of galanin. For example, GALR1 is often linked to Gi/o signaling, while GALR2 can couple to Gq/11.
Regulation and Desensitization
In simple terms: After signaling, receptors can be turned off to prevent overactivity.
Prolonged galanin exposure can lead to receptor desensitization and internalization, a common regulatory mechanism for GPCRs. This process involves phosphorylation by G protein-coupled receptor kinases and recruitment of arrestins, though specific details for galanin receptors are still being elucidated.
Key Genes Involved in GO:0004966 galanin receptor activity
The following genes encode the galanin receptors and related proteins that mediate galanin receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GALR1 | Galanin receptor subtype 1 | Mediates galanin signaling in brain; linked to epilepsy and mood disorders |
| GALR2 | Galanin receptor subtype 2 | Involved in neuroprotection and anxiety-like behavior |
| GALR3 | Galanin receptor subtype 3 | Modulates depression-like behavior and stress responses |
| GAL | Galanin neuropeptide | Endogenous ligand for galanin receptors |
| GNAI1 | Gi/o alpha subunit | Downstream effector of GALR1 signaling |
| GNAQ | Gq alpha subunit | Downstream effector of GALR2 signaling |
| GNA11 | Gq alpha subunit | Downstream effector of GALR2 signaling |
| GNAI2 | Gi/o alpha subunit | Downstream effector of GALR1/GALR3 signaling |
| GNAI3 | Gi/o alpha subunit | Downstream effector of GALR1/GALR3 signaling |
| ARRB1 | Beta-arrestin 1 | Regulates receptor desensitization and internalization |
| ARRB2 | Beta-arrestin 2 | Regulates receptor desensitization and internalization |
| GRK2 | G protein-coupled receptor kinase 2 | Phosphorylates activated receptors |
| GRK3 | G protein-coupled receptor kinase 3 | Phosphorylates activated receptors |
| PRKACA | Protein kinase A catalytic subunit | Downstream effector of cAMP signaling |
| PRKACB | Protein kinase A catalytic subunit | Downstream effector of cAMP signaling |
| PLCB1 | Phospholipase C beta 1 | Downstream effector of Gq signaling |
| PLCB2 | Phospholipase C beta 2 | Downstream effector of Gq signaling |
How Is galanin receptor activity Regulated?
Galanin receptor activity is regulated at multiple levels. Receptor expression levels are controlled by transcriptional mechanisms, and signaling is modulated by desensitization and internalization processes involving GRKs and arrestins. Additionally, the availability of galanin ligand and the specific G protein complement in a cell influence the signaling outcome.
galanin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GALR1 | Epilepsy | GALR1 knockout mouse model |
| GALR2 | Anxiety | GALR2 knockout or overexpression models |
| GALR3 | Depression | GALR3 knockout or point mutation models |
| GAL | Seizure susceptibility | Galanin knockout mice |
| GALR1 | Neuroprotection | GALR1 transgenic overexpression |
Epilepsy
Galanin and its receptors have anticonvulsant properties. Activation of galanin receptor activity reduces seizure susceptibility in animal models, and galanin receptor agonists such as galnon show anticonvulsant activity. Dysregulation of galanin signaling may contribute to epilepsy pathophysiology.
Depression and Anxiety
Galanin receptor activity modulates depression-like and anxiety-like behaviors. Non-selective galanin receptor agonist galnon exhibits anxiolytic-like activity, and galanin receptor subtypes are implicated in depression-like behavior. Targeting these receptors may offer therapeutic avenues for mood disorders.
Neuroprotection and Pain
Galanin receptor activity has been associated with neuroprotective and analgesic effects. The regulatory role of galanin and its receptor subtypes in biological and pathological functions includes modulation of pain pathways and neuronal survival.
From galanin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GALR1 mediate anticonvulsant effects? | GALR1 knockout mouse |
| What is the role of GALR2 in anxiety? | GALR2 knockout or overexpression |
| How does a point mutation affect ligand binding? | CRISPR knock-in of point mutation in GALR1 |
| Can receptor tagging reveal localization? | Tagged knock-in of GALR2 |
| Does overexpression alter signaling? | GALR3 overexpression cell line |
| Which genes interact with galanin receptors? | CRISPR library screening |
How to Study the galanin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Receptor affinity and density | Characterizing galanin receptor subtypes |
| cAMP assay | Gi-mediated inhibition of adenylyl cyclase | GALR1/GALR3 signaling |
| Calcium mobilization | Gq-mediated calcium release | GALR2 signaling |
| CRISPR knockout | Loss of receptor function | Behavioral studies in mice |
| CRISPR knock-in | Point mutations or tags | Structure-function analysis |
| Immunohistochemistry | Receptor localization | Neuroanatomical mapping |
| Behavioral tests | Seizure, anxiety, depression-like behavior | Drug efficacy testing |
Receptor Binding Assays
Radioligand binding assays using labeled galanin or agonists measure receptor affinity and density, providing direct assessment of galanin receptor activity.
Signal Transduction Assays
cAMP inhibition, calcium mobilization, or reporter gene assays quantify downstream signaling following receptor activation, allowing subtype-specific functional analysis.
Genetic Knockout and Knock-in Models
CRISPR/Cas9-mediated knockout or knock-in of GALR genes in mice or cell lines enables causal studies of receptor function in behavior and disease models.
Behavioral Pharmacology
Animal models of epilepsy, anxiety, and depression are used to test galanin receptor agonists and antagonists, linking molecular activity to behavioral outcomes.
How CRISPR Can Be Used to Study GO:0004966 galanin receptor activity
Knockout
CRISPR knockout of GALR1, GALR2, or GALR3 in cell lines or animal models abolishes receptor activity, enabling studies of loss-of-function phenotypes in epilepsy, anxiety, and depression models.
Point Mutation
Introducing point mutations in galanin receptor genes via CRISPR can dissect ligand-binding residues or signaling motifs, revealing structure-function relationships.
Knock-in
Knock-in of tagged receptors (e.g., GFP or HA) allows visualization and biochemical isolation of galanin receptors in native contexts, aiding localization and interaction studies.
Overexpression
CRISPR activation or transgenic overexpression of galanin receptors can enhance signaling, useful for gain-of-function studies and drug screening.
How EDITGENE Supports galanin receptor activity Research
Researchers studying galanin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for galanin receptor activity research.
Frequently Asked Questions About galanin receptor activity
What is galanin receptor activity?
Galanin receptor activity (GO:0004966) is a molecular function defined as combining with galanin to initiate a change in cell activity.
What genes are involved in galanin receptor activity?
The main genes are GALR1, GALR2, and GALR3, which encode the three galanin receptor subtypes.
What diseases are associated with galanin receptor activity?
It is implicated in epilepsy, depression, anxiety, and neuroprotection.
How is galanin receptor activity studied?
Common methods include radioligand binding, cAMP assays, calcium mobilization, and CRISPR knockout models.
What are the subtypes of galanin receptors?
GALR1, GALR2, and GALR3 are the three known subtypes, each with distinct signaling properties.
Can galanin receptor activity be targeted for epilepsy treatment?
Yes, galanin receptor agonists such as galnon show anticonvulsant activity in preclinical models.
What is the role of galanin in depression?
Galanin receptor activity modulates depression-like behavior, and receptor subtypes are implicated in mood disorders.
How does galanin bind to its receptor?
Galanin binds to the extracellular domain of galanin receptors, inducing conformational changes that activate G protein signaling.
What are CRISPR models for galanin receptor research?
Knockout, point mutation, knock-in, and overexpression models allow causal studies of receptor function.
Where can I get custom CRISPR services for galanin receptors?
EDITGENE provides knockout, point mutation, knock-in, overexpression, and screening services for galanin receptor genes.
Conclusion
Galanin receptor activity (GO:0004966) is a fundamental molecular function with broad implications for neurobiology and disease. Understanding its mechanism, key genes, and regulation offers opportunities for therapeutic intervention in epilepsy, depression, and anxiety. CRISPR-based models and EDITGENE services empower researchers to dissect these pathways with precision.
References
- 1. Barreda-Gómez G et al.. 2023. Neuroanatomical characterization of the G protein-coupled receptor activity evoked by galanin-related ligands.. J Chem Neuroanat 128:102226 PMID: 36566994
- 2. Saar K et al.. 2002. Anticonvulsant activity of a nonpeptide galanin receptor agonist.. Proc Natl Acad Sci U S A 99(10):7136-41 PMID: 12011470
- 3. Rajarao SJ et al.. 2007. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.. Neuropeptides 41(5):307-20 PMID: 17637475
- 4. Jiang W et al.. 2022. Structural insights into galanin receptor signaling.. Proc Natl Acad Sci U S A 119(21):e2121465119 PMID: 35594396
- 5. Lerner JT et al.. 2010. Galanin and epilepsy.. Exp Suppl 102:183-94 PMID: 21299069
- 6. Lerner JT et al.. 2008. Galanin and epilepsy.. Cell Mol Life Sci 65(12):1864-71 PMID: 18500639
- 7. Kuteeva E et al.. 2008. Galanin, galanin receptor subtypes and depression-like behaviour.. Cell Mol Life Sci 65(12):1854-63 PMID: 18500640
- 8. Šípková J et al.. 2017. The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.. Physiol Res 66(5):729-740 PMID: 28730831
